Effect of Kinesio Taping and Extracorporeal Shock Wave Therapy on Plantar Fasciitis

NCT06055933 | Completed

• 1 other identifier: ADagbasi001
• Study Type: observational
• Target: 90
• Locations: 1 country
• Sites: 1

Brief Summary

Type of this study: Prospective randomized controlled study. Purpose: The aim of this study is to compare the acute effect of pain level, lower extremity functionality level and plantar fascia flexibility in patients with plantar fasciitis receiving Exportacorporeal Shock Therapy (ESWT). To compare the acute effect of pain level, lower extremity functionality level and plantar fascia flexibility in patients with plantar fasciitis who received KT application in addition to ESWT treatment. To compare the acute effect of pain level, lower extremity functionality level and plantar fascia flexibility in patients with plantar fasciitis receiving placebo application. 90 volunteers will be included in the study as ESWT (n=30), placebo ESWT (n=30), ESWT and KT (n=30) application groups. How effective is ESWT, ESWT and Kinesiotape versus placebo ESWT acutely in the treatment of plantar fasciitis?

Conditions

Plantar Fasciitis

Keywords

Plantar fasciitis; extracorporeal shock wave therapy; ESWT; placebo ESWT; plantar fascia; Kinesio Taping

Outcome Measures

Primary Outcomes (1)

• Visual Analogue Scale (VAS)

  ). VAS, with numbers from 0 to 10 on a 10 cm horizontal line; 0 means "no pain"; It was stated to the patients that 10 represented "unbearable pain". The degree of pain was recorded numerically between 0 and 10

  baseline, post treatment (at 1th week)

Secondary Outcomes (1)

• Lower Extremity Functional Scale

  baseline, post treatment (at 1th week)

Other Outcomes (1)

• Plantar Fascia Elasticity Measurement

  baseline, post treatment (at 1th week)

Study Arms (3)

ESWT

To the ESWT group, with the ESWT device (BTL-6000SWT, UK); Extracorporeal shock wave therapy at 10Hz frequency, 2.5 Barr energy and 2000 shock/session values was applied with a 15 mm head in a single session. Shock waves were applied directly to the most sensitive point detected in the medial of the calcaneus.

Placebo ESWT

The placebo ESWT group was given the ESWT device sound recorded from the external audio device and the application was performed without the ESWT device operating.

ESWT+KT

With ESWT device (BTL-6000SWT, UK); Extracorporeal shock wave therapy at 10Hz frequency, 2.5 Barr energy and 2000 shocks/session was applied in a single session with a 15 mm head. Shock waves will be applied directly to the most sensitive point detected in the medial calcaneus, then a tape consisting of 96% cotton and 4% lycra, water-resistant, porous and adhesive, 5 cm wide and 0.5 mm thick will be used. Taping will be done after the ESWT session and the tape will be asked to remain for a week.

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: male
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Volunteers with a diagnosis of plantar fasciitis and meeting inclusion criteria

You may qualify if:

• Adult cases aged 18-65 years diagnosed with plantar fasciitis by a physical medicine and rehabilitation specialist,
• Cases willing to continue the study,
• In the anamnesis, cases with severe pain when taking the first step after waking up in the morning or after a long period of inactivity and progressive aggravation of the pain as the activity continues,
• Cases whose consent forms were obtained by being informed about the study.

You may not qualify if:

• Cases who have undergone foot and ankle surgery,
• Loss or decrease of sensation in the foot and ankle region for various reasons,
• Difficulty in communication that prevents treatment and evaluations from being carried out effectively,
• Pregnancy,
• Presence of local infection,
• Having a widespread or regional tumoral disease,
• Having circulatory disorders in the lower extremities, bleeding,
• Anticoagulant use,
• Application of other treatment methods such as cold/hot application, exercise, orthosis use, electrotherapy agents,
• Cases with a history of systemic, inflammatory, neurological or vascular disease.

Sponsors & Collaborators

• Necmettin Erbakan University: lead

Study Sites (1)

Necmettin Erbakan Üniversitesi

Konya, 42090, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Fasciitis, Plantar

Condition Hierarchy (Ancestors)

Fasciitis; Musculoskeletal Diseases; Foot Diseases

Study Officials

• Hanife Doğan

  Necmettin Erbakan University

  PRINCIPAL INVESTIGATOR

• abdulkadir dağbaşı

  Necmettin Erbakan University

  STUDY CHAIR

• Aynur Başaran

  Karamanoğlu Mehmetbey University

  STUDY CHAIR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: physiotherapist

Study Record Dates

• First Submitted: September 20, 2023
• First Posted: September 28, 2023
• Study Start: October 2, 2023
• Primary Completion: October 9, 2023
• Study Completion: December 4, 2023
• Last Updated: December 27, 2024

Record last verified: 2024-12

Locations

TU (1)